Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 1937-1938, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sweetman, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sweetman, L.
Related Collections
Right arrow Molecular Diagnostics and Genetics
(Clinical Chemistry. 2001;47:1937-1938.)
© 2001 American Association for Clinical Chemistry, Inc.

Editorial

Newborn Screening by Tandem Mass Spectrometry

Gaining Experience

Lawrence Sweetman1a

1 Institute of Metabolic Disease, Baylor University Medical Center, 3812 Elm Street, Dallas, TX 75226, Fax 214-820-4853

aE-mail l.sweetman@baylordallas.edu

Major expansion of newborn screening for inherited metabolic disorders is taking place across the US and around the world as newer analytical technology is applied. Historically, each disorder to be screened required a separate test with associated costs and requirement for a portion of the dried-blood-spot specimen from a heel stick. This limitation of the existing tests was partially responsible for the limitation of mandated newborn screening in the US to a small number of disorders (usually three to seven, depending on the state).

The technique of tandem mass spectrometric (MS) analysis of dried-blood spots was first proposed for newborn screening in 1990 by Millington et al. (1). Using ionization techniques of fast atom bombardment or liquid secondary ionization with tandem MS, they simultaneously determined a large number of acylcarnitines as an acylcarnitine profile. This allowed newborn screening for numerous inherited fatty acid oxidation and organic acid disorders by a single procedure. Tandem MS was extended to amino acids, including phenylalanine, the screening target for detection of the phenylketonuria (PKU) test (2)(3)(4), and to other disorders, with several such tests described in these pages during the last 8 years (3)(5)(6)(7)(8)(9). The development and application of electrospray ionization (ESI) tandem MS with its ability to be automated made high-volume tandem MS screening for amino acid, organic acid, and fatty acid metabolic disorders practical by the mid-1990s (10)(11)(12).

Automated ESI tandem MS newborn screening of amino acids . . . [Full Text of this Article]


References




The following articles in journals at HighWire Press have cited this article:


Home page
 Health Aff (Millwood)Home page
P. H. Arn
Newborn Screening: Current Status
Health Aff., March 1, 2007; 26(2): 559 - 566.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. H. Chace, T. A. Kalas, and E. W. Naylor
Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
Clin. Chem., November 1, 2003; 49(11): 1797 - 1817.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
M. M. Kushnir, B. Shushan, W. L. Roberts, and M. Pasquali
Serum Acylcarnitines and Vitamin B12 Deficiency
Clin. Chem., July 1, 2002; 48(7): 1126 - 1128.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.